Nilima Prasad Divi is a new generation of leaders who balance corporate excellence with a commitment to philanthropy.
Nilima Prasad Divi, daughter of Hyderabad’s richest man, Dr. Murali K. Divi, is a key figure in the success of Divi’s Laboratories Ltd, one of the world’s largest manufacturers of generic active pharmaceutical ingredients. The company, founded by her father, has a staggering market capitalization of Rs 1.63 lakh crore. Dr. Divi, who serves as its founder and managing director, is also among India’s wealthiest pharma billionaires, with an estimated net worth of $10.1 billion, according to the Bloomberg Billionaires Index.
Nilima’s Role In Divi’s Laboratories
Since joining Divi’s Laboratories in July 2012, Nilima has served as a whole-time Director (Commercial), overseeing critical areas such as material sourcing, procurement, corporate finance, and investor relations. Her strategic insights and leadership have been instrumental in the company’s growth.
Nilima Prasad Divi Education
Nilima is highly qualified, holding a master’s degree in International Business from the Gitam Institute of Foreign Trade and another master’s degree in International Finance from Glasgow University, UK. Before joining her father’s company, she gained substantial commercial experience, particularly in material requirement planning and financing, which equipped her with the skills to excel in the pharmaceutical industry.
In addition to her corporate responsibilities, Nilima serves as a managing trustee of the Divi’s Foundation for Gifted Children, reflecting her commitment to philanthropy and social impact.
Nilima Prasad Divi Property
In May 2024, Nilima made headlines when she purchased two properties in Hyderabad’s prestigious Jubilee Hills for Rs 80 crore. Each property spans 11,000 square feet, showcasing her success and prominence in the region.
Legacy Of Divi’s Laboratories
Divi’s Laboratories, headquartered in Hyderabad, is a global leader in producing over 10 generic active pharmaceutical ingredients. Under the combined leadership of Dr. Divi and Nilima, the company has cemented its place as a powerhouse in the pharmaceutical industry, contributing to both healthcare advancements and economic growth.
With her impressive credentials and vital role in one of the world’s largest pharma companies, she continues to build upon her family’s remarkable legacy.
